The tennis player had been deported and was on his way to Belgrade, when he was caught mid-flight without complying with sanitary measures. The Serbian did not make any statements upon arrival in his country.
Novak Djokovic was photographed without the mask during the flight to Belgrade, after having starred in a scandal that ended with his deportation from Australia. The tennis player could not participate in the first Grand Slam of the season because he was not vaccinated against Covid-19.
The Justice of that country ruled that the Serbian had breached health safety regulations and that is why it ruled against him after several days of uncertainty. After a stopover in Dubai, he finally reached his homeland, where several support marches had been registered during the dispute.
Djokovic’s conflict in Australia
The lawyers had filed with the Australian authorities a positive PCR test from December 16, which could have enabled the tennis player to receive the requested medical exemption. In addition, they left another test with a negative result prior to their trip.
The government of that country attacked the organizers of the tournament to deny that having suffered from Covid-19 up to six months before the event was sufficient reason to receive permission. Meanwhile, the Serbian was isolated in a Melbourne hotel waiting for a definition.
In the documentation presented by his lawyers, a brief was included that could have tipped the balance in his favor. “On December 30, Djokovic received a letter from the Tennis Australia medical director authorizing a medical exemption for his recent recovery., was highlighted as a snippet.
However, the tennis player made a post on his Twitter account December 17 with a series of images during an event held in your country. The positive PCR delivered by her lawyers is from the day before, so it could be thought that when these photographs were taken I knew I was infected.
Djokovic bought a company to treat Covid-19
The Serb acquired 80 percent of the Danish biotech firm QuantBioRes, which aims to develop an alternative medical treatment to the vaccine to counteract the coronavirus. The investment was made in June 2020 in an amount that has not been disclosed so far.